Phathom Pharmaceuticals, Inc. (PHAT) Max Pain Analysis

Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.

Phathom Pharmaceuticals, Inc. (PHAT) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.00B, listed on NASDAQ, employing roughly 427 people, carrying a beta of 0.57 to the broader market. Phathom Pharmaceuticals, Inc. Led by Steven L. Basta, public since 2019-10-25.

Snapshot as of May 15, 2026.

Spot Price
$12.00
Total OI
29.6K

Learn how max pain is reported and how to read the data →